A carregar...
Programmed death ligand‐1 expression in gastrointestinal cancer: Clinical significance and future challenges
Cancer immunotherapy has caused a paradigm shift from conventional therapies that directly target cancer cells to innovative therapies that utilize the host immune system. In particular, programmed cell death‐1 (PD‐1)/programmed death ligand‐1 (PD‐L1) inhibitors have achieved an impressive breakthro...
Na minha lista:
| Publicado no: | Ann Gastroenterol Surg |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7382440/ https://ncbi.nlm.nih.gov/pubmed/32724880 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ags3.12348 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|